Likewise, high EPO (>16.9 mU/mL) had high specificity (1.0; 95% CI 0.89–1.0) but low sensitivity (0.16; 95% CI, 0.11–0.21) for JAK2-negative (secondary) erythrocytosis. The gene discussed is JAK2; the disease is polycythemia.